Mottahedin et al. (2019) and Deng et al. (2020) have demonstrated that TLR2 participates in microglia activation and peripheral immune cell infiltration in ischemic stroke. Administration of the inhibitor targeting TLR2 decreased the release of pro-inflammatory cytokines (Wang et al., 2020). The gene discussed is TLR2; the disease is ischemic stroke.